🏥Amended Notice of Meeting - Center for Scientific Review, NIH
The Department of Health and Human Services announces a change in the meeting schedule for the Oncology 2—Translational Clinical Integrated Review Group, including a new contact for the Scientific Review Officer. The meeting is closed to the public and takes place at the National Institutes of Health in Bethesda, MD.
Learn More💊FDA Guidance on Chemotherapy-Induced Peripheral Neuropathy Available
The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: Developing Drug and Biological Products in Oncology." Chemotherapy-induced peripheral neuropathy (CIPN), a painful, disabling, and potentially irreversible condition commonly affecting patients receiving neurotoxic chemotherapies, could diminish survival by potentially increasing chemotherapy treatment interruptions, dose reductions, and discontinuations. This guidance provides recommendations to sponsors for the clinical development of drug and biological products intended for the prevention and treatment of CIPN in oncology patient populations.
Learn More